Sensient Technologies Corp SXT
We take great care to ensure that the data presented and summarized in this overview for SENSIENT TECHNOLOGIES CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding SXT
View all-
Black Rock Inc. New York, NY6.43MShares$504 Million0.01% of portfolio
-
Winder Pte. Ltd. Singapore, U06.3MShares$494 Million16.23% of portfolio
-
Winder Investment Pte LTD6.3MShares$494 Million18.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.02MShares$393 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X02.23MShares$175 Million0.09% of portfolio
-
State Street Corp Boston, MA1.63MShares$128 Million0.01% of portfolio
-
Nordea Investment Management Ab Stockholm, V71.5MShares$117 Million0.13% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.32MShares$103 Million0.62% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.21MShares$94.7 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA946KShares$74.1 Million0.01% of portfolio
Latest Institutional Activity in SXT
Top Purchases
Top Sells
About SXT
Sensient Technologies Corporation, together with its subsidiaries, develops, manufactures, and markets colors, flavors, and other specialty ingredients in North America, Europe, the Asia Pacific, and internationally. It operates through three segments: Flavors & Extracts Group, Color Group, and Asia Pacific Group. The company offers flavor-delivery systems, and compounded and blended products; ingredient products, such as essential oils, natural and synthetic flavors, and natural extracts; and chili powder, paprika, and chili pepper, as well as dehydrated vegetables comprising parsley, celery, and spinach to the food, beverage, personal care, and household-products industries. It also provides natural and synthetic color systems for use in foods, beverages, pharmaceuticals, and nutraceuticals; colors and other ingredients for cosmetics, such as active ingredients, solubilizers, and surface treated pigments; pharmaceutical and nutraceutical excipients, including colors, flavors, coatings, and nutraceutical ingredients; and technical colors for industrial applications under the Sensient Food Colors, Sensient Pharmaceutical Coating Systems, Sensient Cosmetic Technologies, and Sensient Industrial Colors trade names. The company was incorporated in 1882 and is headquartered in Milwaukee, Wisconsin.
Insider Transactions at SXT
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 14
2024
|
Gebhardt Deborah Mc Keithan Director |
SELL
Open market or private sale
|
Indirect |
2,000
-100.0%
|
$142,000
$71.08 P/Share
|
Jul 01
2024
|
Adam Vanderleest VP, Controller, and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
190
+13.64%
|
-
|
Jul 01
2024
|
Tobin Tornehl VP and Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
747
+7.17%
|
-
|
May 17
2024
|
Essie Whitelaw Director |
SELL
Open market or private sale
|
Direct |
1,037
-4.75%
|
$77,775
$75.75 P/Share
|
May 10
2024
|
Essie Whitelaw Director |
SELL
Open market or private sale
|
Direct |
600
-2.68%
|
$45,000
$75.84 P/Share
|
Apr 30
2024
|
Steven B Morris President, Flavors Group |
SELL
Open market or private sale
|
Direct |
400
-8.92%
|
$28,800
$72.97 P/Share
|
Apr 25
2024
|
Carol R Jackson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
564
-9.93%
|
$38,916
$69.64 P/Share
|
Apr 25
2024
|
Carol R Jackson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,436
+20.18%
|
-
|
Apr 25
2024
|
Mario Ferruzzi Director |
SELL
Payment of exercise price or tax liability
|
Direct |
564
-6.12%
|
$38,916
$69.64 P/Share
|
Apr 25
2024
|
Mario Ferruzzi Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,436
+13.48%
|
-
|
Apr 25
2024
|
Joseph Carleone Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,436
+6.83%
|
-
|
Apr 25
2024
|
Brett W Bruggeman Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,436
+50.0%
|
-
|
Apr 25
2024
|
Scott C Morrison Director |
SELL
Payment of exercise price or tax liability
|
Direct |
271
-2.65%
|
$18,699
$69.64 P/Share
|
Apr 25
2024
|
Scott C Morrison Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,436
+12.33%
|
-
|
Apr 25
2024
|
Gebhardt Deborah Mc Keithan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,436
+8.69%
|
-
|
Apr 25
2024
|
Donald W Landry Director |
SELL
Payment of exercise price or tax liability
|
Direct |
271
-2.96%
|
$18,699
$69.64 P/Share
|
Apr 25
2024
|
Donald W Landry Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,436
+13.57%
|
-
|
Apr 25
2024
|
Sharad P Jain Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,436
+25.01%
|
-
|
Apr 25
2024
|
Essie Whitelaw Director |
SELL
Payment of exercise price or tax liability
|
Direct |
564
-2.45%
|
$38,916
$69.64 P/Share
|
Apr 25
2024
|
Essie Whitelaw Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,436
+5.88%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 65.1K shares |
---|---|
Exercise of conversion of derivative security | 67K shares |
Payment of exercise price or tax liability | 54.5K shares |
---|---|
Open market or private sale | 6.65K shares |